TNFRSF9 and malignant colon neoplasm: BH-3120 further crosslinked PD-L1 on human colon cancer (DLD-1) cells expressing PD-L1 and CD137 on GS-H2 cells expressing CD137, producing IL-8, thereby mediating CD137 receptor agonistic activity.